The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.


Updates from The Motley Fool

Latest updates on Smith and Nephew from Fool.com.  The Fool has written over 100 articles on Smith and Nephew.
Intel Staves Off the Dow's Drop

Smith & Nephew's stock recedes from recent highs as investors continue to circle the possibility ...



Stock Performance

View Interactive SNN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Smith and Nephew.
Current Price: $31.46
Prev Close: $31.65
Open: $31.48
Bid: $25.15
Ask: $0.00
Day's Range: $31.34 - $31.56
52wk Range: $26.96 - $35.38
Volume: 491,244
Avg Vol 548,629
Market Cap: $14B
P/E (ttm): 25.73
EPS (ttm): $0.00
Div & Yield: $0.74 (3.1%)

Company Rating

What our community thinks about Smith and Nephew.
CAPS Rating 4 out of 5
 
118 Outperform
11 Underperform
CAPS All Stars
 
32 Outperform
3 Underperform

How do you think Smith and Nephew will perform against the market?



You pick for Smith and Nephew is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Olivier Bohuon, CEO

63% Approve

Based on 109 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Smith and Nephew.

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT